No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus

Abstract

The aim of this study was to determine the potential role of three IRF3 gene polymorphisms (rs2304204, rs7251 and rs2304207) with systemic lupus erythematosus (SLE). Our study population consisted of 610 patients with SLE and 730 healthy controls. All individual were of Spanish Caucasian origin. The IRF3 polymorphisms were genotyped using a PCR system with pre-developed TaqMan allelic discrimination assay. No statistically significant differences were found when allele and genotype distribution of rs2304204, rs7251 and rs2304207 polymorphisms were compared between patients with SLE and controls [overall P values: rs7251, P = 0.06; rs2304204, P = 0.26 and rs2304207, P = 0.36, by chi-squared test on a 3 × 2 contingency table. Overall allelic P values: rs7251, P = 0.8, OR (95%CI) = 1.03 (0.87–1.22); rs2304204, P = 0.2, OR (95%CI) = 1.12 (0.93–1.34) and rs2304207, P = 0.8, OR (95%CI) = 1.02 (0.82–1.26)]. In addition, no evidence of association with haplotypes and clinical features of SLE was found. Our data suggest that the IRF3 polymorphisms do not appear to play a major role in the susceptibility or severity of SLE in a Spanish population.

Keywords

autoimmune disease IRF3 polymorphisms susceptibility systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

1 Alarcon-Riquelme ME . The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility. Springer Semin Immunopathol 2006; 28: 109–117.

2 Graham RR Kozyrev SV Baechler EC . A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550–555 (letter).

3 Kozyrev SV Abelson AK Wojcik J . Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008; 40: 211–216 (letter).

4 Kyogoku C Langefeld CD Ortmann WA . Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004; 75: 504–507.

5 Orozco G Sanchez E Gonzalez-Gay MA . Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005; 52: 219–224.

6 Prokunina L Castillejo-Lopez C Oberg F . A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666–669 (letter).

7 Baechler EC Batliwalla FM Karypis G . Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610–2615.

8 Bennett L Palucka AK Arce E . Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711–723.

9 Kirou KA Lee C George S . Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3958–3967.

10.

10 Pascual V Farkas L Banchereau J . Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 2006; 18: 676–682.

11.

11 Barnes BJ Kellum MJ Field AE Pitha PM . Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol 2002; 22: 5721–5740.

12.

12 Barnes BJ Moore PA Pitha PM . Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 2001; 276: 23382–23390.

13.

13 Mamane Y Heylbroeck C Genin P . Interferon regulatory factors: the next generation. Gene 1999; 237: 1–14.

14.

14 Sato M Suemori H Hata N . Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000; 13: 539–548.

15.

15 Sigurdsson S Nordmark G Goring HH . Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005; 76: 528–537.

16.

16 Moser KL Neas BR Salmon JE . Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A 1998; 95: 14869–14874.

17.

17 Lindqvist AK Steinsson K Johanneson B . A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 2000; 14: 169–178.

18.

18 Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725 (letter).

19.

19 Sanchez E Gomez LM Lopez-Nevot MA . Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 2006; 7: 433–436.

20.

20 Barrett JC Fry B Maller J Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.

21.

21 Dudbridge F . Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115–121.

22.

22 Koutouzov S Mathian A Dalloul A . Type-I interferons and systemic lupus erythematosus. Autoimmun Rev 2006; 5: 554–562.

23.

23 Mathian A Weinberg A Gallegos M Banchereau J Koutouzov S . IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black × New Zealand White) F1 but not in BALB/c mice. J Immunol 2005; 174: 2499–2506.

24.

24 Santiago-Raber ML Baccala R Haraldsson KM . Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003; 197: 777–788.

25.

25 Braun D Geraldes P Demengeot J Type I . Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J Autoimmun 2003; 20: 15–25.

26.

26 Sigurdsson S Goring HH Kristjansdottir G . Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 2008; 17: 872–881.

27.

27 Kawasaki A Kyogoku C Ohashi J . Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: Support for a crucial role of intron 1 polymorphisms. Arthritis Rheum 2008; 58: 826–834.

28.

28 Goriely S Molle C Nguyen M . Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood 2006; 107: 1078–1084.

29.

29 Lauwerys BR Van Snick J Houssiau FA . Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity. Lupus 2002; 11: 384–387.

30.

30 Tokano Y Morimoto S Kaneko H . Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)–relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 1999; 116: 169–173.

31.

31 Sanchez E Morales S Paco L . Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44: 1136–1139.

32.

32 Sanchez E Rueda B Callejas JL . Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens 2007; 70: 233–237.

33.

33 Sanchez E Orozco G Lopez-Nevot MA Jimenez-Alonso J Martin J . Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63: 54–57.

34.

34 Orozco G Sanchez E Collado MD . Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2005; 65: 183–186.